MetaADEDB 2.0 @ LMMD
(2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-3-ium-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(DXVUYOAEDJXBPY-NFFDBFGFSA-N)
Structure
SMILES
OC(=O)[C@@H]1N2C(=O)[C@H]([C@H]2SC1(C)C)N1C(=O)[C@H](NC1(C)C)c1ccccc1
Type(s)
Approved; Vet_approved; Withdrawn
ATC code(s)
J01CA18
Molecular Formula:
C19H23N3O4S
Molecular Weight:
389.469
Log P:
1.6157
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
2
TPSA:
115.25
CAS Number(s):
3511-16-8
Synonym(s)
1.
(2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-3-ium-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
2.
Hetacillin
External Link(s)
PubChem Compound443387
40473404
ChEBI5683
CHEMBLCHEMBL1201116
DrugBankDB00739
DrugCentral1363
KEGGcpd:C11729
dr:D01074
ZINC4102186
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainCanada Vigilance: 2Canada Vigilance
2DyspepsiaCanada Vigilance: 1Canada Vigilance
3ErythemaCanada Vigilance: 2Canada Vigilance
4FatigueCanada Vigilance: 1Canada Vigilance
5FlatulenceCanada Vigilance: 1Canada Vigilance
6HeadacheCanada Vigilance: 1Canada Vigilance
7UrticariaCanada Vigilance: 4Canada Vigilance
8VomitingCanada Vigilance: 1Canada Vigilance
9jaundiceCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.